Amoxicillin NDC 0093-2264

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-2264Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-2264Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-2264-01	00093226401	100 TABLET, FILM COATED in 1 BOTTLE (0093-2264-01)Marketed from Sep 26, 2000

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amoxicillin
Generic name (nonproprietary): amoxicillin
Active ingredients: Amoxicillin — 875 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065056
Marketing start: Sep 26, 2000
Listing expires: Dec 31, 2026
Other FDA classes: Penicillins (Chemical structure)
Identifiers: Product ID 0093-2264_31223839-1653-4906-826a-f9d6af179334SPL ID 31223839-1653-4906-826a-f9d6af179334SPL set ID 4c0f348a-a65d-409c-8668-207c82a5e3cbRxCUI 239191, 308177, 308182, 308189, 308191, 308192, 308194, 313850, 598025UNII 804826J2HUUPC 0300933107051, 0300932264014, 0300934161731, 0300933109055, 0300932267015, 0300932268012, 0300932263017, 0300934160734, 0300934155730
Pharmacologic class: Penicillin-class Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093226401 followed by a unit qualifier and the quantity

Package 00093-2264-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 22, 2024.

Indications (excerpt from the label)

Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin tablets, amoxicillin for oral suspension, amoxicillin tablets (chewable), and amoxicillin capsules are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of Streptococcus species. (α- and β-hemolytic isolates only), Streptococcus pneumoniae , Staphylococcus spp., or Haemophilus influenzae . Infections of the Genitourinary Tract: Amoxicillin tablets, amoxicillin for oral suspension, amoxicillin tablets (chewable), and amoxicillin capsules are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of E…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065056

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065056
Product	Strength	Form · route	Labeler	Product NDC
Amoxicillin	Amoxicillin 500 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-2263
Amoxicillin	Amoxicillin 875 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-085
Amoxicillin	Amoxicillin 500 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-084
Amoxicillin	Amoxicillin 875 mg/1	Tablet, Film coatedOral	QPharma, Inc.	42708-112